Efficacy of platelet-rich plazma (PRP) terapy in uterine scar healing after cesarean section

Abstract

According to the World Health Organization, the global rate of cesarean sections (CS) has significantly increased over the past three decades, reaching 25–30%, and even 40–50% in major perinatal centers. Evaluation of postCS reparative processes, uterine healing, and scar quality is crucial, particularly in the context of preventing uterine scar dehiscence. However, there is limited data on methods to enhance reparative activity and promote robust scar formation. In 1985, David Knighton pioneered the use of platelet-rich plasma (PRP) in treating chronic trophic ulcers. Due to its regenerative properties, PRP has emerged as a promising modality in tissue repair